Bactiguard products

Our infection prevention
solutions reduce the risk of
infections, increase patient
safety and reduce the use of
antibiotics.

Bactiguard products

The Future of Life Science

For Expo 2020, Bactiguard’s Chief Medical Officer Stefan Grass gathered with representatives from three other Swedish life science companies to discuss global health challenges such as antimicrobial resistance.

 

Bactiguard is an official partner of the Swedish pavilion at Expo 2020 in Dubai.

The Future of Life Science

First orthopedic implants with Bactiguard's infection prevention technology available to patient

In 2019, Bactiguard and Zimmer Biomet partnered to develop and launch orthopedic trauma implants with Bactiguard’s infection prevention technology, to prevent post-operative infections. European regulatory clearance for The Zimmer Natural Nail (ZNN) Bactiguard implants was obtained in January 2021. They are launched in Germany, Spain, and the UK, and will be made available to patients and surgeons in other select EMEA (Europe, Middle East and Africa) markets gradually.

Prevention is better than cure

Each year 1 of 10 patients are affected by healthcare associated
infections, HAI, globally. The most common HAI is urinary tract infection and a large majority is caused by indwelling urinary catheters.

 

Bactiguard’s BIP Foley catheters decrease the risk of catheter associated urinary tract infection.

 

Prevention is better than cure

Capital injection initiates a new phase of accelerated expansion

Bactiguard Holding AB (publ) published the interim report for the third quarter on Thursday October 28, 2021 at 8:00 CET.

Link to webcast

Presentation

Capital injection initiates a new phase of accelerated expansion

Bactiguard’s Annual Report 2020 - great collaborations and global expansion

Bactiguard’s Annual Report 2020 is now available for downloading in both Swedish and English. Find out about Bactiguard’s significant strategic advances and how we stand stronger than ever, ready to impact and drive change within infection prevention. Both in healthcare and in people’s everyday life.

Interim report Q3 (January - September) 2021

Bactiguard Holding AB (publ) published the interim report for the third quarter on Thursday October 28, 2021 at 8:00 CET.

Our products prevent healthcare associated infections

The Bactiguard technology reduces microbial adhesion to the surface of medical devices, which decreases the risk of biofilm formation leading to infection.

Combines surveillance and infection prevention

The BIP Foley TempSensor is an indwelling urinary catheter which combines continuous temperature monitoring with Bactiguard’s infection prevention technology.

Bactiguard Wound Care

For cleaning, soothing and moisturizing acute, chronic and infected wounds. Creates a clean wound bed by removing bacteria, fungi and spores, while supporting the natural healing.